MENU

Mark Andrake, PhD

Mark Andrake, PhD
About

Assistant Research Professor

Adjunct Professor, Department of Medical Genetics and Molecular Biochemistry, Lewis Katz School of Medicine, Temple University

TRDG Member,

Breast Cancer;

Colorectal and SI Cancer;

Esophagus, Pancreas, and Liver Cancer;

Kidney, Bladder, and Prostate Cancer;

Lung Cancer and Mesothelioma

Research Program

 

Education and Training

Educational Background

  • Postdoctoral Fellow, Fox Chase Cancer Center, Philadelphia, PA 1994
  • PhD, Molecular Genetics, Medical University of South Carolina, Charleston, SC, 1991
  • BS, Biochemistry, Carnegie Mellon University, Pittsburgh, PA, 1982
  • Training, Advanced Proton  Source, Argonne National Laboratory, Argonne, IL

Honors & Awards

  • Principal Investigator, Awarded Two SAXS General User Proposals with beam time, APS, Argonne National Labs, 2010
  • NIH Individual Postdoctoral National Research Service Award, 1992
  • NCI Postdoctoral Trainee Award, National Cancer Institute, 1991
  • First Prize, PhD Poster Presentation, MUSC Student Research Day, 1989
  • First Prize, PhD Oral Presentation, MUSC Student Research Day, 1988
  • Elected Student Representative, Medical University of South Carolina, 1986
  • Graduate Assistantship, Medical University of South Carolina, 1985
  • Member, Beta Beta Beta Biological Honor Society, 1981
Research Profile

Research Program

Research Interests

Structure and biochemistry of retroviral integrases and other early events of retroviral infection

  • Early events of retroviral infection and the cellular proteins associated with pre-integration complexers
  • Biochemistry and multimerization of retroviral integrases
  • The structure of retroviral integrases as investigated by X-ray cruystallography, small angle X-ray scattering and various other biophysical and computational methods
  • Screening for and development of allosteric inhibitors of integrase function
  • Viral restriction by the host factor Daxx protein
  • Use of computational modeling methods to understand and target a variety of cancer related proteins

Lab Overview

My lab studies the early events of retroviral infection, with a focus on the essential viral integrase protein that inserts viral DNA into the host genome. Integrase is a validated target for antiviral therapeutics including those that target HIV-AIDS and potentially other retroviral-induced cancers. One project in the lab is centered on the host proteins that associate with the pre- integration complex (PIC), including both factors that are co-opted by the virus to promote replication and those that represent the host cell’s innate immune response to incoming viral infection. We are interested in discerning the molecular interactions of the host restriction factor Daxx with the integrase protein of the PIC, and how that results in silencing of proviral expression.

Secondly, our major focus has been to understand the biochemistry, enzymology, multimerization and structure of retroviral integrases. We have utilized a variety of biophysical methods to characterize the structure of integrases, including small angle X-ray scattering, X- ray crystallography, catalytic assays, and methods to detect multimerization, and integrase-DNA binding. Currently we are using computational methods to engineer an HIV-integrase that forms stable complexes with viral DNA (called intasomes) that are amenable to crystallography trials and structure determination. The absence of an atomic resolution description of the HIV intasome is a major deficit in the development of anti-HIV therapeutics. In addition, we are currently screening for small molecule allosteric inhibitors that interfere with integrase multimerization as a new strategy for anti- retroviral therapeutics.

Lastly, in managing the Fox Chase Molecular Modeling Facility, I have enjoyed being a part of a collaborative team environment for translational medicine. The facility has contributed to important papers involving epigenetics and mitosis, cell signaling, kinase inhibition in cancer therapeutics, and nucleosome structure and regulation. In addition to collaborating with laboratory investigators, more recently I have been assisting clinical investigators in interpreting the results of sequencing of tumor samples and germline DNA by determining the likely impact of missense mutations on protein function and cellular processes. With the advent of incorporating tumor gene sequencing technologies to the diagnostic repertoire of personalized cancer care, there is a pressing need to understand the structural and biochemical effects of the mutations that are found. Since 2011, we have undertaken projects with 15 investigators dealing with the structural and functional consequences of missense mutations identified in breast, kidney, prostate, bladder, lung, genitourinary, colon and other GI cancers. 

Lab Staff

Yu Chung Chang, PhD

Postdoctoral Associate, 50% effort in the Andrake Lab

Room: W410
215-728-2867

George Merkel, MS

Scientific Associate

Room: R422
215-728-3669

Taryn Serman

Summer Undergraduate Fellow

Room: R428
215-728-3609

Zaigham Khan, PhD

Postdoctoral Associate

Room: R428
215-728-3609
Publications

Selected Publications

Bojja, R.S., Andrake, M.D., Merkel, G., Weigand, S., Dunbrack, R.L., Jr., Skalka, A.M. Architecture and assembly of HIV integrase multimers in the absence of DNA substrates. J. Biol. Chem. 288:7373-7386, 2013. PubMed

Peletskaya, E., Andrake, M., Gustchina, A., Merkel, G., Alexandratos, J., Zhou, D., Bojja, R.S., Satoh, T., Potapov, M., Kogon, A., Potapov, V., Wlodawer, A., Skalka, A.M. Localization of ASV integrase-DNA contacts by site-directed crosslinking and their structural analysis. PLoS One 6:e27751, 2011. PubMed

Katz, R.A., Merkel, G., Andrake, M.D., Roder, H., Skalka, A.M. Retroviral integrases promote fraying of viral DNA ends. J. Biol. Chem. 286:25710-25718, 2011. PubMed

Bojja, R.S., Andrake, M.D., Weigand, S., Merkel, G., Yarychkivska, O., Henderson, A., Kummerling, M., Skalka, A.M. Architecture of a full-length retroviral integrase monomer and dimer, revealed by small angle X-ray scattering and chemical cross-linking. J. Biol. Chem. 286:17047-17059, 2011. PubMed

Andrake, M.D., Ramcharan, J., Merkel, G., Zhao, X.Z., Burke, T.R., Jr., Skalka, A.M. Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution. AIDS Res. Ther.6:14, 2009. PubMed

Merkel, G., Andrake, M.D., Ramcharan, J., Skalka, A.M. Oligonucleotide-based assays for integrase activity. Methods 47:243-248, 2009. PubMed

Andrake, M.D., Sauter, M.M., Boland, K., Goldstein, A.D., Hussein, M., Skalka, A.M. Nuclear import of Avian Sarcoma Virus integrase is facilitated by host cell factors. Retrovirology 5:73, 2008. PubMed

Andrake MD, Skalka AM. Retroviral integrase, putting the pieces together. J Biol Chem. 1996 Aug 16;271(33):19633-6. PubMed.

Andrake MD, Skalka AM. Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase. J Biol Chem. 1995 Dec 8;270(49):29299-306. PubMed

Additional Publications

My NCBI

This Fox Chase professor participates in the Undergraduate Summer Research Fellowship
Learn more about Research Volunteering.

Connect with Fox Chase